Naphthylpropylaminopentane
Chemical compound
Naphthylpropylaminopentane[edit]

Naphthylpropylaminopentane (also known as NPPAP) is a chemical compound that belongs to the class of substituted amphetamines. It is primarily known for its role as a research chemical and has been studied for its potential effects on the central nervous system.
Chemical Structure and Properties[edit]
Naphthylpropylaminopentane is structurally related to amphetamines, characterized by the presence of a naphthyl group attached to a propyl chain, which is further connected to an aminopentane moiety. This unique structure contributes to its pharmacological properties and potential effects on neurotransmitter systems.
The chemical formula for Naphthylpropylaminopentane is C16H23N, and it has a molecular weight of 229.36 g/mol. The presence of the naphthyl group is significant as it influences the compound's lipophilicity and ability to cross the blood-brain barrier.
Pharmacology[edit]
Naphthylpropylaminopentane is known to act as a monoamine releasing agent, primarily affecting the release of dopamine and norepinephrine in the brain. This action is similar to that of other stimulant compounds, which can lead to increased alertness, energy, and euphoria. However, the exact mechanism of action and the full spectrum of its effects are not fully understood and require further research.
Potential Uses and Research[edit]
While Naphthylpropylaminopentane has been studied in laboratory settings, it is not approved for medical use. Its potential applications are primarily in the field of neuroscience research, where it is used to study the effects of monoamine release on behavior and brain function. Researchers are interested in its potential to model certain neurological conditions and to explore new treatments for disorders involving dopamine dysregulation.
Safety and Legal Status[edit]
As a research chemical, Naphthylpropylaminopentane is not regulated in many jurisdictions, but it may be subject to control under analog laws due to its structural similarity to controlled substances. The safety profile of Naphthylpropylaminopentane is not well-established, and it should be handled with caution in research settings. Potential risks include neurotoxicity, cardiovascular effects, and psychological dependence.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian